Hypothyroidism: Difference between revisions
Line 31: | Line 31: | ||
* Congenital hypothyroidism | * Congenital hypothyroidism | ||
* Autoimmune (Hashimoto's) thyroiditis | * Autoimmune (Hashimoto's) thyroiditis | ||
* Resistance to TSH | |||
| | | | ||
* Thyroidectomy | * Thyroidectomy | ||
Line 54: | Line 55: | ||
* Postpartum thyroiditis | * Postpartum thyroiditis | ||
| | | | ||
* Major suegeries | |||
| | | | ||
* | |||
|- | |- | ||
| rowspan="2" |Central Hypothyroidism | | rowspan="2" |Central Hypothyroidism | ||
Line 156: | Line 159: | ||
! colspan="2" rowspan="2" style="background:#DCDCDC;" |Disease | ! colspan="2" rowspan="2" style="background:#DCDCDC;" |Disease | ||
! colspan="5" align="center" style="background:#DCDCDC;" |History and symptoms | ! colspan="5" align="center" style="background:#DCDCDC;" |History and symptoms | ||
! colspan=" | ! colspan="7" align="center" style="background:#DCDCDC;" |Laboratory findings | ||
! rowspan="2" align="center" style="background:#DCDCDC;" |Additional findings | ! rowspan="2" align="center" style="background:#DCDCDC;" |Additional findings | ||
|- | |- | ||
Line 170: | Line 173: | ||
! align="center" style="background:#DCDCDC;" |Thyroglobin | ! align="center" style="background:#DCDCDC;" |Thyroglobin | ||
! align="center" style="background:#DCDCDC;" |TRH | ! align="center" style="background:#DCDCDC;" |TRH | ||
! align="center" style="background:#DCDCDC;" | | ! align="center" style="background:#DCDCDC;" |Anti TPO | ||
|- | |- | ||
| | | rowspan="2" style="background:#DCDCDC;" |Primary hypothyroidism | ||
|Hashimoto | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | ||
Line 185: | Line 188: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''↑''' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''↑''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |''' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Auto antibodies present | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Auto antibodies present | ||
([[GAD65|Anti GAD-65]] and anti insulin anti bodies) | ([[GAD65|Anti GAD-65]] and anti insulin anti bodies) | ||
|- | |||
|Non-authoimmune | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
| | |||
|- | |- | ||
| colspan="2" style="background:#DCDCDC;" |Transient hypothyroidism | | colspan="2" style="background:#DCDCDC;" |Transient hypothyroidism | ||
Line 203: | Line 220: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Acanthosis nigricans]] | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Acanthosis nigricans]] | ||
|- | |- | ||
Line 219: | Line 235: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
|- | |- | ||
Line 236: | Line 251: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | Other hormonal deficiencies | ||
|- | |- | ||
| align="center" style="padding: 5px 5px; background: #DCDCDC;" |Hypothalamus | | align="center" style="padding: 5px 5px; background: #DCDCDC;" |Hypothalamus | ||
Line 248: | Line 262: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |↓ | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |↓ | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
|- | |- | ||
| colspan="2" style="background:#DCDCDC;" | | | colspan="2" style="background:#DCDCDC;" |Resistance to thyroid hormone | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
Line 265: | Line 278: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |In hospitalized patients especially in [[ICU]] and [[CCU]] | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |In hospitalized patients especially in [[ICU]] and [[CCU]] | ||
|- | |- | ||
Line 280: | Line 292: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''↑''' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''↑''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Acanthosis nigricans|Acanthosis nigricans,]] | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Acanthosis nigricans|Acanthosis nigricans,]] | ||
|- | |- | ||
| | | style="background:#DCDCDC;" |[[RTA|RTA 1]] | ||
| | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
Line 295: | Line 307: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Hypokalemia]], [[nephrolithiasis]] | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Hypokalemia]], [[nephrolithiasis]] | ||
|- | |- | ||
| | | style="background:#DCDCDC;" |[[Glucagonoma]] | ||
| | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
Line 313: | Line 325: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Necrolytic migratory erythema]] | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Necrolytic migratory erythema]] | ||
|- | |- | ||
| | | style="background:#DCDCDC;" |[[Cushing's syndrome|Cushing syndrome]] | ||
| | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
Line 328: | Line 340: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''↑''' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |N/'''↑''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |'''↑''' | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Normal | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Moon face]], [[obesity]], [[buffalo hump]], easy [[Bruising|bruisibility]] | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |[[Moon face]], [[obesity]], [[buffalo hump]], easy [[Bruising|bruisibility]] |
Revision as of 14:55, 11 July 2017
For patient information click here
Hypothyroidism Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]
Synonyms and keywords: Myxedema; myxoedema; thyroid activity decreased; hypothyroid
Overview
Classification
Origin of the defect | Causes | ||||||
---|---|---|---|---|---|---|---|
Endagenous causes | Exagenous causes | ||||||
Thyroid | Pituirtary | Hypothalamus | Surgery or radiation | Other causes | |||
Primary hypothyroidism | + | - | - |
|
|
| |
Transient hypothyroidism | + | + | - |
|
|
| |
Central Hypothyroidism | Secondary
OR Pituitary originated |
- | + | - |
|
|
|
Tertiary
OR Hypothalamus originated |
- | - | + |
|
|
|
hei
- Primary hypothyroidism
- Congenital hypothyroidism
- Autoimmune (Hashimoto's) thyroiditis
- Iodine deficeincy
- Drug induced thyroiditis
- Amiodarone
- Lithium
- Thionamide
- Iodine
- Iterferon
- Sunitinib
- Rifampicin
- Thalidomide
- Thyroidectomy
- Radioiodine therapy
- Transient hypothyroidism
- Subacute (de Quervain’s) thyroiditis
- Postpartum thyroiditis
- Secondary hypothyroidism (due to decreased levels of TSH)
- Pituitary mass lesions, especially pituitary adenomas
- cysts and abscesses
- meningiomas
- dysgerminomas
- metastatic tumors
- craniopharyngiomas
- surgery or radiation therapy for pituitary adenomas or other mass lesions near pituitary gland
- head trauma with injury of the stalk
- pituitary apoplexy
- Sheehan syndrome (postpartum pituitary necrosis)
- Idiopathic isolated TSH deficiency
- Tertiary hypothyroidism
- Infiltrative disorders affecting the pituitary or the hypothalamus include hemochromatosis, and histiocytosis
- autoimmune lymphocytic hypophysitis
- Developmental abnormalities
- internal carotid aneurysms
- Other central nervous system (CNS) tumors
- Idiopathic isolated TRH deficiency
Differential diagnosis
Disease | History and symptoms | Laboratory findings | Additional findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Goiter | TSH | Free T4 | T3 | T3RU | Thyroglobin | TRH | Anti TPO | ||||||
Primary hypothyroidism | Hashimoto | + | + | + | + | - | ↑ | ↓ | Normal or ↓ | Normal | N/↑ | Normal | ↑ | Auto antibodies present
(Anti GAD-65 and anti insulin anti bodies) |
Non-authoimmune | ||||||||||||||
Transient hypothyroidism | + | + | + | + | - | ↑ | ↑ | Normal | Normal | ↑ | Normal | Normal | Acanthosis nigricans | |
Subclinical hypothyroidism | + | + | + | - | + | ↑ | Normal | Normal | Normal | ↑ | Normal | Normal | - | |
Central Hypothyroidism | Pituitary | + | + | - | - | - | Normal or ↓ | Normal or ↓ | Normal or ↓ | ↓ | Normal | Normal | Normal | Other hormonal deficiencies |
Hypothalamus | + | + | - | - | - | ↑ | Normal | ↓ | Normal | - | ||||
Resistance to thyroid hormone | - | - | - | - | - | ↑ | ↑ | Normal | Normal | ↑ | Normal | Normal | In hospitalized patients especially in ICU and CCU | |
Steroid therapy | + | - | - | - | + | ↑ | ↑ | Normal | Normal | ↑ | ↑ | N/↑ | Acanthosis nigricans, | |
RTA 1 | - | - | - | + | - | Normal | Normal | ↑ | Normal | ↑ | Normal | Normal | Hypokalemia, nephrolithiasis | |
Glucagonoma | - | - | - | - | - | ↑ | Normal | Normal | Normal | - | Normal | Normal | Necrolytic migratory erythema | |
Cushing syndrome | - | - | - | - | + | ↑ | - | Normal | ↓ | N/↑ | ↑ | Normal | Moon face, obesity, buffalo hump, easy bruisibility |
General feature
Symptoms
Constituitional | Local | Reproductive | Neuropsysiological | Others | Physical exam | |
---|---|---|---|---|---|---|
cold intolerance
puffiness decreased sweating coarse skin hypothermia Fever if accompanied by thyroiditis weight gain coarse, brittle, straw like hair with hair loss |
obstructive sleep apnea (secondary to macroglossia) | Females can present with galactorrhea and menstrual disturbances | depression | paresthesia and nerve entrapment syndromes | decreased systolic blood pressure
increased diastolic blood pressure bradycardia pericardial effusion abdominal distension ascites (uncommon) non-pitting edema (myxedema) pitting edema of lower extremities hyporeflexia with delayed relaxation ataxia | |
fullness and pain in the throat and neck | infertility | emotional lability | constipation | |||
|
blurred vision | macroglossia | ||||
goiter | Attention deficit | periorbital puffiness | ||||
slowed speech and movements |
- Metabolic abnormalities associated with hypothyroidism include:
- anemia,
- dilutional hyponatremia,
- hyperlipidemia,
- reversible increase in creatinine
Complications
Myxedema coma
Rare, severe form of hypothyroidism, a life-threatening condition
- Altered mental status,
- hypothermia,
- bradycardia,
- hypercarbia, and
- hyponatremia.
- Cardiomegaly,
- pericardial effusion,
- cardiogenic shock, and
- ascites
- commonly occurs in individuals with undiagnosed or untreated hypothyroidism who is subjected to an external stress, such as low temperature, infection, or medical intervention (e.g., surgery or hypnotic drugs)